163 related articles for article (PubMed ID: 35945827)
1. A Retrospective Study from a Single Center to Identify Hematological Factors that Distinguish Between Patients with Colorectal Carcinoma and Colorectal Adenoma.
Huang J; Xu P; Chen Y
Med Sci Monit; 2022 Aug; 28():e936745. PubMed ID: 35945827
[TBL] [Abstract][Full Text] [Related]
2. Predictive model using hemoglobin, albumin, fibrinogen, and neutrophil-to-lymphocyte ratio to distinguish patients with colorectal cancer from those with benign adenoma.
Záhorec R; Marek V; Waczulikova I; Veselovský T; Palaj J; Kečkéš Š; Durdík Š
Neoplasma; 2021 Nov; 68(6):1292-1300. PubMed ID: 34585586
[TBL] [Abstract][Full Text] [Related]
3. The combined detection of hematological indicators is used for the differential diagnosis of colorectal cancer and benign-colorectal lesions.
Zhang X; Wu YY; Qin YY; Lin FQ
Cancer Biomark; 2024; 39(3):223-230. PubMed ID: 38217586
[TBL] [Abstract][Full Text] [Related]
4. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and CEA as the Potential Prognostic Biomarkers for Colorectal Cancer.
Ming-Sheng F; Mei-Ling D; Xun-Quan C; Yuan-Xin H; Wei-Jie Z; Qin-Cong P
Can J Gastroenterol Hepatol; 2022; 2022():3109165. PubMed ID: 35028301
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
7. Identification of kininogen-1 as a serum biomarker for the early detection of advanced colorectal adenoma and colorectal cancer.
Wang J; Wang X; Lin S; Chen C; Wang C; Ma Q; Jiang B
PLoS One; 2013; 8(7):e70519. PubMed ID: 23894665
[TBL] [Abstract][Full Text] [Related]
8. Circulating fibrinogen to pre-albumin ratio is a promising biomarker for diagnosis of colorectal cancer.
Sun F; Tan YA; Gao QF; Li SQ; Zhang J; Chen QG; Jiang YH; Zhang L; Ying HQ; Wang XZ
J Clin Lab Anal; 2019 Jan; 33(1):e22635. PubMed ID: 30047185
[TBL] [Abstract][Full Text] [Related]
9. Colorectal Cancer Detected by Machine Learning Models Using Conventional Laboratory Test Data.
Li H; Lin J; Xiao Y; Zheng W; Zhao L; Yang X; Zhong M; Liu H
Technol Cancer Res Treat; 2021; 20():15330338211058352. PubMed ID: 34806496
[No Abstract] [Full Text] [Related]
10. The Importance of Determining Preoperative Serum Concentration of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Assessing the Progression of Colorectal Cancer.
Halilovic E; Rasic I; Sofic A; Mujic A; Rovcanin A; Hodzic E; Kulovic E
Med Arch; 2020 Oct; 74(5):346-349. PubMed ID: 33424087
[TBL] [Abstract][Full Text] [Related]
11. Association of visceral obesity and early colorectal neoplasia.
Choe EK; Kim D; Kim HJ; Park KJ
World J Gastroenterol; 2013 Dec; 19(45):8349-56. PubMed ID: 24363527
[TBL] [Abstract][Full Text] [Related]
12. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study.
Sui J; Wu X; Wang C; Wang G; Li C; Zhao J; Zhang Y; Xiang J; Xu Y; Nian W; Cao F; Yu G; Lou Z; Hao L; Liu L; Li B; Zhang Z; Cai S; Liu H; Lan P; Zhang W
Clin Epigenetics; 2021 Feb; 13(1):26. PubMed ID: 33536049
[TBL] [Abstract][Full Text] [Related]
13. Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer.
Kim ER; Kwon HN; Nam H; Kim JJ; Park S; Kim YH
Sci Rep; 2019 Mar; 9(1):4786. PubMed ID: 30886205
[TBL] [Abstract][Full Text] [Related]
14. Serum Levels of BDNF in Patients with Adenoma and Colorectal Cancer.
Wang Z; Wang S; Liu Y; Gao S; Yu Y; Hu Z
Dis Markers; 2021; 2021():8867368. PubMed ID: 33628340
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a 92 multiplex protein panel in detection of colorectal cancer and high-risk adenoma in 784 symptomatic individuals.
Rasmussen L; Nielsen HJ; Christensen IJ
Cancer Biomark; 2021; 32(1):73-84. PubMed ID: 34092616
[TBL] [Abstract][Full Text] [Related]
16. Risk prediction models based on hematological/body parameters for chemotherapy-induced adverse effects in Chinese colorectal cancer patients.
Li M; Chen J; Deng Y; Yan T; Gu H; Zhou Y; Yao H; Wei H; Chen W
Support Care Cancer; 2021 Dec; 29(12):7931-7947. PubMed ID: 34213641
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of Carcinoembryonic Antigen in Ascites for Colorectal Cancer with Peritoneal Carcinomatosis.
Song SE; Choi P; Kim JH; Jung K; Kim SE; Moon W; Park MI; Park SJ
Korean J Gastroenterol; 2018 Jun; 71(6):332-337. PubMed ID: 29943560
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Hematologic and Other Prognostic Markers in Metastatic Colorectal Cancer.
Mercier J; Voutsadakis IA
J Gastrointest Cancer; 2019 Sep; 50(3):493-506. PubMed ID: 29704170
[TBL] [Abstract][Full Text] [Related]
19. Prothrombin time (PT) and CEA as prognostic predictive biomarkers for postoperative recurrence after curative resection in patients with stage I-III colorectal cancer: a retrospective cohort study.
Ma L; Li W; Liu N; Ding Z; Cai J; Zhang Y
Updates Surg; 2022 Jun; 74(3):999-1009. PubMed ID: 35322387
[TBL] [Abstract][Full Text] [Related]
20. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]